The company’s board approved a quarterly payout of 86 cents per share, up from the previous rate of 80 cents. This adjustment brings the total annual dividend to $3.44 per share, representing a 1.8% yield based on the recent closing price of $191.25. According to the company, the increased dividend is payable on April 20 to shareholders of record as of the close of business on April 6.

Capital Allocation and Shareholder Returns

Beyond the dividend hike, the board significantly bolstered its stock-buyback program. The new $1 billion authorization adds to the approximately $400 million that remained under the previous plan at the end of 2025. This expansion allows the company to continue its aggressive equity reduction strategy as it manages its substantial cash reserves.

With a market capitalization currently exceeding $21 billion, Quest Diagnostics remains a dominant force in the diagnostic information services sector. The company’s latest financial maneuvers reflect a steady approach to maintaining investor confidence through consistent direct payouts and strategic share repurchases.